Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Combination drugs

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison May 01, 2023 9:01pm

151 Views

Post# 35424111

RE:Combination drugs

enriquesuave am I wrong to say even if Keytruda + CG007 is 85% ours at 83 TR seems a far superior and more likely to be recommended by Oncologists once BTD plus AA puts Theralase into commercialization!
In my mind SOC is more real with each patient update

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant